KEGG pathway enrichment analysis showed that GpM treatment of EC mainly involved the PI3K-AKT signaling pathway, MAPK signaling pathway, and IL-17 signaling pathway, all of which are associated with tumor diseases. This evidence concerns the gene IL17A and neoplasm.